Diabetic foot infection severity

01Purpose and principlesWhat the assessment is for and the core concepts behind it.

Every open chronic wound acquires microorganisms, but diabetic foot infection is defined clinically by invasion and an inflammatory response. At least two findings among swelling or induration, erythema, tenderness or pain, increased warmth and purulent discharge support infection after alternatives are excluded. Neuropathy, PAD and immune dysfunction may blunt signs; conversely Charcot arthropathy, gout, fracture, venous disease and pressure injury can imitate inflammation. Culture identifies organisms only after the clinical decision that infection is present.

Severity predicts urgency and likely treatment burden. A mild infection affects skin or subcutaneous tissue only, with erythema more than 0.5 cm but less than 2 cm and no systemic manifestations. Moderate infection is deeper or has erythema at least 2 cm, without systemic manifestations. Severe infection combines local infection with at least two SIRS findings. Host and limb context then modifies disposition: ischaemia, renal failure, poor glycaemic control, immunosuppression, deep collections and inability to adhere can justify admission or faster specialist care even without formal severe criteria.

Key points

Severe diabetic foot infection means local infection with systemic manifestations; manage urgently in acute services with sepsis care, parenteral therapy when needed and early surgical assessment.
Infection with gangrene, deep abscess, necrotising features or significant ischaemia threatens the limb even if observations are normal; obtain urgent surgical and vascular input.
Diagnose infection clinically when at least two inflammatory findings are present, including swelling, erythema, tenderness, warmth or purulent discharge, after excluding mimics; culture alone shows colonisation.
Mild infection is superficial, without systemic features, and has erythema extending more than 0.5 cm but less than 2 cm; deeper disease or erythema at least 2 cm is moderate.
Collect tissue from the cleansed and debrided wound, or bone when osteomyelitis is suspected, before or as close as possible to starting antibiotics.
Start antibiotics promptly once infection is suspected; use oral treatment when the person can take it and severity does not require intravenous therapy.
Review intravenous therapy by 48 hours and switch to oral when possible; reassess at 1–2 days if improvement has not begun or sooner if deterioration occurs.
Do not give antibiotics to an uninfected ulcer to prevent infection or accelerate healing; continue offloading, perfusion management and wound care.

02Indications, selection and cautionsWhen it is useful, when urgency changes and important limitations.

Uninfected ulcer

No purulence and insufficient local or systemic inflammatory findings are present. Slough, malodour or a positive surface culture alone is not diagnostic. Reassess perfusion, pressure and wound care, because a non-healing ulcer still requires active management even when antibiotics are not indicated.

Mild infection

Inflammation is confined to skin and subcutaneous tissue, erythema extends more than 0.5 cm but less than 2 cm, and no systemic manifestations occur. Verify that deeper structures, abscess, osteomyelitis and significant ischaemia are absent before accepting this low grade.

Moderate infection

Erythema extends at least 2 cm or infection involves tendon, muscle, joint or bone, but systemic manifestations are absent. Look deliberately for abscess, tracking, exposed structures, tissue necrosis and PAD; these determine admission and source-control urgency.

Severe infectionRed flag

Severe infection is local infection with at least two SIRS findings: temperature >38°C or <36°C; heart rate >90/min; respiratory rate >20/min or PaCO2 <4.3 kPa (32 mmHg); white count >12,000/mm³, <4,000/mm³ or >10% bands. Hypotension, confusion or organ dysfunction signals even greater danger.

Risk-amplifying context

PAD, gangrene, extensive necrosis, renal failure, immunosuppression, severe hyperglycaemia, recent antibiotics, resistant organisms, poor social support and inability to offload worsen risk. These factors influence admission and regimen choice without automatically redefining the formal infection grade.

Red flags requiring action

Fever, tachycardia, tachypnoea, hypotension, confusion, rigors or metabolic deterioration indicates systemic illness and may meet severe infection criteria.
Crepitus, bullae, skin anaesthesia, dusky necrosis, severe pain out of proportion or rapid spread raises concern for necrotising soft-tissue infection.
Fluctuance, purulent tracking, deep tenderness, exposed joint or bone, or gas on imaging suggests an abscess or deep compartment infection requiring source control.
A cool foot, gangrene, absent Doppler signals or severe perfusion deficit accompanying infection requires urgent vascular and surgical coordination.

03Method and interpretationA systematic approach to the test and its findings.

Investigation order

Read from the initial assessment onwards. Tests may run in parallel in urgent care; first-line, preferred, confirmatory, definitive and gold-standard labels appear only when the chapter explicitly states them.

01
Deep tissue or bone microbiologyFirst step
Why
Identify likely pathogens and enable de-escalation after the clinical diagnosis of infection is made.
Interpretation and limitations
Cleanse and debride, then collect tissue aseptically from the wound base; take bone rather than soft tissue when osteomyelitis is suspected. A deep swab is a fallback if tissue cannot be obtained. Interpret growth with prior antibiotics and sampling quality.
02
Bedside severity assessment
Why
Grade infection as uninfected, mild, moderate or severe and expose features that require urgent surgery or admission.
Interpretation and limitations
Measure erythema, probe for depth and collections, examine perfusion and record observations and organ function. At least two SIRS findings define severe infection; deeper involvement or erythema at least 2 cm without systemic manifestations is moderate.
03
Plain radiographs
Why
Look for gas, foreign body, deformity and bone changes and provide a baseline when deep infection is possible.
Interpretation and limitations
Gas in tissues or destructive change changes urgency. Early osteomyelitis can have a normal film; repeat imaging or MRI may be needed when suspicion persists.
04
CRP, ESR, full blood count and metabolic panel
Why
Support severity assessment when the examination is equivocal and detect systemic effects or prescribing constraints.
Interpretation and limitations
High inflammatory markers support infection but are nonspecific; normal results do not exclude osteomyelitis or local infection. Check glucose, ketones when relevant, renal function, electrolytes and lactate according to illness severity.
05
MRI or targeted cross-sectional imaging
Why
Define deep collections and osteomyelitis when clinical assessment and plain radiographs leave uncertainty.
Interpretation and limitations
MRI maps soft tissue and marrow but reactive oedema from Charcot change, trauma or recent surgery reduces specificity. Imaging complements rather than postpones drainage of an obvious collection.

04Clinical next stepsHow the result changes management or prompts escalation.

01Acute treatmentFrom severity to immediate actionFirst stepClinical infection is present, after rapidly excluding sepsis, necrotising disease, abscess, gangrene and critical ischaemia.

1For severe or limb-threatening features, refer immediately, obtain urgent surgical and vascular assessment, take blood and deep cultures where indicated, and start sepsis management and intravenous antibiotics without harmful delay.
2For mild or stable moderate infection, obtain a debrided tissue specimen before or close to antibiotics, choose oral therapy when absorption and severity allow, and define a review point and stop duration.
3Review response, cultures and renal function; narrow treatment when results support it, switch intravenous therapy toward oral by 48 hours when possible, and reassess urgently if no early improvement.
4Continue offloading, perfusion correction, glucose management and appropriate debridement because antibiotics alone cannot remove pressure, restore blood flow or drain pus.

02Preferred branchDeep or complicated infectionPreferredDeep abscess, compartment involvement, necrosis, gangrene, exposed structures, osteomyelitis or infection with PAD is suspected.

1Request urgent surgical consultation; early surgery within roughly 24–48 hours may be needed to remove infected and necrotic tissue in moderate or severe disease.
2Coordinate vascular evaluation when PAD accompanies infection or gangrene so that drainage, debridement and revascularisation sequence protect both life and limb.
3Send operative tissue and bone specimens, revise therapy to microbiology and findings, and preserve viable tissue while achieving adequate drainage.

03No infectionColonised but clinically uninfected ulcerThe wound lacks purulence and sufficient inflammatory findings after careful examination and exclusion of masked deep disease.

1Do not prescribe systemic or topical antibiotics merely for bacterial growth, odour, prevention or an attempt to accelerate closure.
2Treat mechanical pressure, ischaemia, devitalised tissue and moisture balance; arrange multidisciplinary review and clear warning signs.
3Re-examine promptly if erythema, warmth, swelling, pain, discharge, systemic illness or wound deterioration appears.

05Procedure and medicine safetyRelevant preparation, treatment and contraindications.

NICE first-choice oral treatment for mild diabetic foot infection when likely pathogens are susceptible.

Flucloxacillin

For mild infection, 500 mg orally four times daily for 7 days; extend by up to 7 further days only after clinical review of response.

Confirm no immediate or severe penicillin allergy and avoid after flucloxacillin-associated jaundice or hepatic dysfunction. Usual renal function needs no reduction; at creatinine clearance <10 mL/min the SmPC requires dose reduction or interval extension, caps adults at 1 g every 8–12 hours, and gives no dialysis supplement, so use a named renal-antimicrobial or pharmacist schedule. Stop or change for hypersensitivity, hepatic injury, resistance or deterioration.

NICE alternative oral option for a mild infection when a penicillin cannot be used.

Clarithromycin

For mild infection with penicillin allergy or intolerance, 500 mg orally twice daily for 7 days; extend by up to 7 days only after reassessment.

Check macrolide allergy, QT prolongation, hepatic disease and CYP3A interactions including simvastatin or lovastatin. At creatinine clearance <30 mL/min halve this 500 mg twice-daily regimen to 250 mg twice daily and do not continue beyond 14 days; severe hepatic failure with renal impairment is contraindicated. Avoid routine use in pregnancy when erythromycin is the NICE-listed alternative; narrow or stop by response and cultures.

A NICE regimen providing broader aerobic and anaerobic cover in moderate or severe diabetic foot infection.

Co-amoxiclav

For moderate or severe infection, 500/125 mg orally three times daily or 1.2 g intravenously three times daily; treat at least 7 days, extending up to 6 weeks for osteomyelitis according to specialist assessment.

Avoid in serious penicillin allergy or previous co-amoxiclav-associated jaundice. If creatinine clearance is >30 mL/min use the stated dose; at 10–30 use 500/125 mg orally twice daily, or after an initial 1.2 g IV dose use 500/100 mg IV twice daily; below 10 use the oral dose once daily, or initial 1.2 g IV then 500/100 mg IV every 24 hours. During haemodialysis, give oral 500/125 mg every 24 hours plus a dose during and after dialysis, or IV initial 1.2 g then 500/100 mg every 24 hours plus 500/100 mg after dialysis. Review IV therapy by 48 hours and narrow by response.

Optional additional Gram-negative cover in selected moderate or severe infection within a monitored regimen.

Gentamicin

Initially 5–7 mg/kg intravenously once daily; determine subsequent doses and interval from serum concentrations, renal function and specialist antimicrobial guidance.

Use measured weight and local concentration protocol; monitor renal function and drug levels and avoid or minimise concurrent nephrotoxic or ototoxic medicines. Pregnancy, frailty and renal impairment need specialist risk assessment; stop when cultures and response allow de-escalation.

06Risks, monitoring and follow-upComplications, safety checks and further assessment.

Mark and measure erythema, record wound depth, discharge, necrosis, pain, temperature, pulse and systemic observations, and compare findings at every review.
Advise immediate help if symptoms worsen rapidly or significantly; if improvement has not begun within 1–2 days, reassess diagnosis, perfusion, source control, adherence and antibiotic choice.
Review microbiology as soon as available and choose a narrower effective agent when appropriate; distinguish a true pathogen from colonising growth and contamination.
If intravenous antibiotics are used, review by 48 hours for oral switch, toxicity and ongoing indication; monitor renal function closely with gentamicin or other nephrotoxic therapy.
After osteomyelitis treatment, assess for remission over at least six months after antibiotics end, including wound closure, recurrence, inflammatory change and new tissue loss.

07Special situationsVariants, exceptions and circumstances that change the usual approach.

Grade and disposition differ

Infection grade describes clinical extent and systemic response. Admission also depends on ischaemia, need for surgery, metabolic instability, parenteral therapy, home support and ability to offload; a moderate infection may still require hospital care.

Inflammation can be muted

Neuropathy, PAD and immune dysfunction can reduce pain, warmth or erythema. Examine depth, perfusion and systemic trajectory and use biomarkers or imaging when the examination is equivocal, while remembering normal tests do not exclude bone infection.

Antibiotics cannot drain pus

Failure despite apparently active therapy should prompt a search for an abscess, necrotic tissue, foreign material, osteomyelitis, severe ischaemia or an incorrect diagnosis before simply broadening the regimen.

Pseudomonas is contextual

Routine empirical antipseudomonal cover is not recommended in temperate climates without relevant recent culture or exposure context. Previous results, recent antibiotics, local resistance and infection severity should shape choices.

Skin recovery lags

Some discoloration can persist after adequate treatment, so duration should follow the whole clinical response rather than cosmetic normality alone. Continued or worsening inflammation, however, requires active reassessment.

08Common pitfallsFrequent interpretation and management errors.

01
Treating every positive swab exposes the person to harm and resistance while neglecting pressure, ischaemia and wound care.
02
Calling an infection mild without measuring erythema or examining depth misses moderate disease and delays source control.
03
Waiting for cultures or MRI before starting therapy in a clinically infected, deteriorating foot creates avoidable delay; sample first only when this is immediately achievable.
04
Broadening antibiotics repeatedly without checking perfusion and drainage mistakes an anatomical failure for a drug-selection problem.
05
Using an unadjusted aminoglycoside regimen in renal impairment risks toxicity; measured dosing, levels and renal monitoring are integral to the prescription.

Find your next topic